Literature DB >> 15475472

Neuropathic pain in children with cancer.

Eufemia Jacob1.   

Abstract

Different mechanisms of cancer pain may involve somatic, visceral, and neural tissues. Pain that involves the neural tissues is classified as neuropathic pain and is less responsive to analgesics than pain that involves somatic and visceral tissues. Because young children are unable to describe the quality of pain, presence of neuropathic pain with cancer may be unrecognized and undetected. The purpose of this article is to explain the nature of neuropathic pain, to review the literature related to children with cancer that suggests the presence of neuropathic pain, to outline assessment strategies that may lead to appropriate detection of neuropathic pain in children, and to discuss challenges in the management of neuropathic pain. Future research is needed to characterize the intensity, location, quality, and duration of neuropathic pain in children. In addition, research that would determine the efficacy of opioids, nonsteroidal anti-inflammatory drugs, and adjuvant analgesics (antidepressants, anticonvulsants) is needed to increase the nurses' ability to assess and manage neuropathic pain in children with cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15475472     DOI: 10.1177/1043454204270251

Source DB:  PubMed          Journal:  J Pediatr Oncol Nurs        ISSN: 1043-4542            Impact factor:   1.636


  3 in total

1.  Methadone use in children and young adults at a cancer center: a retrospective study.

Authors:  Doralina L Anghelescu; Lane G Faughnan; Gisele M Hankins; Deborah A Ward; Linda L Oakes
Journal:  J Opioid Manag       Date:  2011 Sep-Oct

2.  Treatment of pain in children after limb-sparing surgery: an institution's 26-year experience.

Authors:  Doralina L Anghelescu; Linda L Oakes; Gisele M Hankins
Journal:  Pain Manag Nurs       Date:  2010-09-20       Impact factor: 1.929

3.  Neuropathic Pain in Pediatric Oncology: A Clinical Decision Algorithm.

Authors:  Doralina L Anghelescu; Jessica Michala Tesney
Journal:  Paediatr Drugs       Date:  2019-04       Impact factor: 3.022

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.